Special Issue Introduction
Special issue webinar:
Liver Tumors of Unidentified Primary: are All HCC or HCC-CCA?Participants
1. Yao Luo Oncology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China.
2. Luis Alberto Martinez Insfran Department of Surgery, Hospital Universitario San Juan de Alicante, Alicante, Spain.
3. Federica Pedica Department of Experimental Oncology, Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
4. Sarah El-Nakeep Gastroenterology and Hepatology Unit, Internal Medicine Department , Faculty of Medicine, Ain Shams University, Cairo, Egypt.
5. Luca Aldrighetti Hepatobiliary and General Surgery Division, San Raffaele Hospital, Milan, Italy.
6. Valli De Re Immunopathology and Cancer Biomarkers/Bioproteomic facility, Department of Translational Research, Centro di Riferimento Oncologico (CRO) IRCCS, Cancer Institute, Aviano, Italy.
7. Anna Rossetto Department of General Surgery and Transplantation, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
8. Amir A Rahnemai-Azar Division of Surgical Oncology, Department of Surgery, Arrowhead Regional Cancer Center, California University of Science and Medicine, Colton, CA, USA.
Hepatoma Research
